EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Outcome After Modern Proton Beam Therapy in Childhood Craniopharyngioma: Results of the Prospective Registry Study KiProReg

Martin Bischoff, Dalia Ahmad Khalil, Sabine Frisch, Claus M Bäcker, Sarah Peters, Carsten Friedrich, Stephan Tippelt, Rolf-Dieter Kortmann, Brigitte Bison, Hermann L Müller, Beate Timmermann

International Journal of Radiation Oncology*Biology*Physics · 2024

DOI: 10.1016/j.ijrobp.2024.03.015 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Radiation Oncology*Biology*Physics, 2024. Verfasst von Martin Bischoff und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Particle Therapy, University Hospital Essen, West German Proton Therapy Centre Essen (WPE), West German Cancer Centre (WTZ), Essen, Ger…. Hauptthemen laut MEDLINE: Craniopharyngioma, Proton Therapy, Pituitary Neoplasms, Registries. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Deutsche Kinderkrebsstiftung.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: Craniopharyngiomas (CPs) are rare tumors of the sellar region often leading to significant comorbidities due to their close proximity to critical structures. The aim of this study was to analyze survival outcome and late toxicities after surgery and proton beam therapy (PBT) in childhood CPs. METHODS AND MATERIALS: Within the prospective registry study "KiProReg" (DRKS0000536), data of 74 childhood patients with CP, receiving PBT between August 2013 to June 2022 were eligible. Late toxicities were analyzed according to the grading system of the Common Terminology Criteria for Adverse Events, version 4.0. RESULTS: Median follow-up since first diagnosis was 4.3 years (range, 0.8-14.7). In addition, 75.7% of patients received PBT at time of disease progression or recurrence, whereas 24.3% as part of their primary therapy (definitive or adjuvant). Predominantly (85.1%), pencil beam scanning technique was used. The median total dose and initial tumor volume were 5400 cGy relative biologic effectiveness (RBE) and 17.64 cm³ (range, 3.07-300.59), respectively. The estimated (±SE) 3-year overall survival, progression-free, and cystic failure-free survival rate after PBT were 98.2% (±1.7), 94.7% (±3.0), and 76.8% (±5.4), respectively. All local failures (n = 3) were in-field relapses necessitating intervention and occurred exclusively in patients receiving PBT at progression or recurrence. Early cystic enlargements after PBT were typically asymptomatic and self-limiting. Fatigue, headaches, vision disorders, obesity, and endocrinopathies were the predominant late toxicities. No high-grade (≥3) new-onset visual impairment or cognitive deterioration occurred compared with baseline. The presence of cognitive impairments at the end of follow-up correlated with size of the planning target volume (P = .034), Dmean dose to the temporal lobes (P = .032, P = .045) and the number of surgical interventions before PBT (P = .029). CONCLUSIONS: Our findings demonstrate favorable local control rates using modern PBT with acceptable late toxicities. Cyst growth within 12 months after radiation therapy is typically not associated with tumor progression. Longer follow-up must be awaited to confirm results.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CraniopharyngiomaProton TherapyPituitary NeoplasmsRegistriesHumansChildMaleFemaleProspective StudiesChild, PreschoolAdolescentTreatment OutcomeTumor BurdenNeoplasm Recurrence, LocalRadiotherapy DosageInfantRelative Biological Effectiveness

Autor:innen und Institutionen

  • Department of Particle Therapy, University Hospital Essen, West German Proton Therapy Centre Essen (WPE), West German Cancer Centre (WTZ), Essen, Germany; Department of Radiation Oncology, Ruhr-University Bochum, Medica…
  • Department of Particle Therapy, University Hospital Essen, West German Proton Therapy Centre Essen (WPE), West German Cancer Centre (WTZ), Essen, Germany.
  • West German Proton Therapy Centre Essen (WPE), West German Cancer Centre (WTZ), Essen, Germany.
  • Department of Pediatrics and Pediatric Hematology/Oncology, University Children's Hospital, Carl von Ossietzky University Oldenburg, Klinikum Oldenburg AöR, Oldenburg, Germany.
  • Department of Pediatrics III, Pediatric Oncology and Hematology, University Hospital Essen, Essen, Germany.
  • Department of Radiation Oncology, University of Leipzig, Leipzig, Germany.

Förderung

  • Deutsche Kinderkrebsstiftung

Zitieren

APA

Bischoff, M., Khalil, D. A., Frisch, S., Bäcker, C. M., Peters, S., Friedrich, C., Tippelt, S., Kortmann, R. D., Bison, B., Müller, H. L., & Timmermann, B. (2024). Outcome After Modern Proton Beam Therapy in Childhood Craniopharyngioma: Results of the Prospective Registry Study KiProReg. International Journal of Radiation Oncology*Biology*Physics. https://doi.org/10.1016/j.ijrobp.2024.03.015

Vancouver

Bischoff M, Khalil DA, Frisch S, Bäcker CM, Peters S, Friedrich C, et al. Outcome After Modern Proton Beam Therapy in Childhood Craniopharyngioma: Results of the Prospective Registry Study KiProReg. International Journal of Radiation Oncology*Biology*Physics. 2024. doi:10.1016/j.ijrobp.2024.03.015

BibTeX
@article{Bischoff2024,
  author = {Bischoff, Martin and Khalil, Dalia Ahmad and Frisch, Sabine and Bäcker, Claus M and Peters, Sarah and Friedrich, Carsten and Tippelt, Stephan and Kortmann, Rolf-Dieter and Bison, Brigitte and Müller, Hermann L and Timmermann, Beate},
  title = {Outcome After Modern Proton Beam Therapy in Childhood Craniopharyngioma: Results of the Prospective Registry Study KiProReg},
  journal = {International Journal of Radiation Oncology*Biology*Physics},
  year = {2024},
  doi = {10.1016/j.ijrobp.2024.03.015}
}
Kostenlos starten →